Fertility preservation in Turkey: a global look for nationwide strategy development

Ünlü, Mehmet Cihat; Güven, Davut; Bakay, Kadir; ÖNDER, Sevgen Çelik; YILDIRIM, Osman Gazi; basbug, alper; hatirnaz, safak; HATIRNAZ, Ebru

doi:10.4274/jtgga.galenos.2019.2018.0116

Fertility preservation in Turkey: a global look for nationwide strategy development

Şafak HATIRNAZ, (İn Vitro Fertilizasyon-IVM Merkezi, Medicana Samsun International Hospital, Samsun, Türkiye)

Kadir BAKAY, (Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Kadın Hastalıkları ve Doğum Anabilim Dalı, Samsun, Türkiye)

Ebru HATIRNAZ, (İn Vitro Fertilizasyon-IVM Merkezi, Medicana Samsun International Hospital, Samsun, Türkiye)

Davut GÜVEN, (Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Kadın Hastalıkları ve Doğum Anabilim Dalı, Samsun, Türkiye)

Alper BAŞBUĞ, (Düzce Üniversitesi, Tıp Fakültesi, Kadın Hastalıkları ve Doğum Anabilim Dalı, Düzce, Türkiye)

Sevgen Çelik ÖNDER, (Özel Ofis, Uşak, Türkiye)

Osman Gazi YILDIRIM, (Yeditepe Üniversitesi, Tıp Fakültesi, Kadın Hastalıkları ve Doğum Anabilim Dalı, İstanbul, Türkiye)

Cihat ÜNLÜ (Acıbadem Üniversitesi, Tıp Fakültesi, Kadın Hastalıkları ve Doğum Anabilim Dalı, İstanbul, Türkiye)

Journal of the Turkish-German Gynecological Association

9 0

Yıl: 2019 Cilt: 20 Sayı: 3 Sayfa Aralığı: 196 - 207 Metin Dili: İngilizce DOI: 10.4274/jtgga.galenos.2019.2018.0116 İndeks Tarihi: 11-10-2020

Fertility preservation in Turkey: a global look for nationwide strategy development

Öz:

As the reproductive technology advanced along with the improved outcome in cancer treatment demands implementing new fertility preservation,developing algorithms on fertility preservation requires tailoring for each society. Here, the authors attempt to modify the current medicalliterature on fertility preservation for the Turkish population. A PubMed search was conducted using the search term fertility preservation. Initially,280 items of literature were accessed. In the second evaluation, 126 articles were examined and 154 items were discarded due to the low qualityof the literature. In the final round, only 68 publications that were the most relevant were found eligible for inclusion in this review article. Inorder to develop a more systematic national guideline, forming a multidisciplinary approach to create a web-based network would be the firststep. Both physicians and patients will have open access to the information. This database should be linked to an international consortium tostay integrated and open for updating. The aim of this review was to evaluate the relationship between the current situation in our country andthe developments in the world in light of the literature, and to establish infrastructure for the development of future approaches in our country.(J Turk Ger Gynecol Assoc 2019; 20: 196-207)

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık

1. Gracia CR, Sammel MD, Freeman E, Prewitt M, Carlson C, Ray A, et al. Impact of cancer therapies on ovarian reserve. Fertil Steril 2012; 97: 134-40.e1.
2. West ER, Zelinski MB, Kondapalli LA, Gracia C, Chang J, Coutifaris C, et al. Preserving female fertility following cancer treatment: current options and future possibilities. Pediatr Blood Cancer 2009; 53: 289-95.
3. Ataman LM, Rodrigues JK, Marinho RM, Caetano JP, Chehin MB, Alves da Motta EL, et al. Creating a Global Community of Practice for Oncofertility. J Glob Oncol 2016; 2: 83-96.
4. von Wolff M, Germeyer A, Liebenthron J, Korell M, Nawroth F. Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part II: fertility preservation techniques. Arch Gynecol Obstet 2018; 297: 257-67.
5. González C, Boada M, Devesa M, Veiga A. Concise review: fertility preservation: an update. Stem Cells Transl Med 2012; 1: 668-72.
6. Gardino SL, Jeruss JS, Woodruff TK. Using decision trees to enhance interdisciplinary team work: the case of oncofertility. J Assist Reprod Genet 2010; 27: 227-31.
7. Forman EJ, Anders CK, Behera MA. Pilot survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients. J Reprod Med 2009; 54: 203-7.
8. Küçük M, Yavaşoğlu I, Bolaman AZ, Kadıköylü G. Knowledge, attitudes, and practices of hematologists regarding fertility preservation in Turkey. Turk J Haematol 2013; 30: 269-74.
9. Loren AW, Brazauskas R, Chow EJ, Gilleece M, Halter J, Jacobsohn DA, et al. Physician perceptions and practice patterns regarding fertility preservation in hematopoietic cell transplant recipients. Bone Marrow Transplant 2013; 48: 1091-7.
10. Forman EJ, Anders CK, Behera MA. A nationwide survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients. Fertil Steril 2010; 94: 1652-6.
11. Hotaling JM, Laufer N, Rosenwaks Z. Introduction: Cancer biomarkers and fertility. Fertil Steril 2018; 109: 4-5.
12. Hanson BM, Eisenberg ML, Hotaling JM. Male infertility: a biomarker of individual and familial cancer risk. Fertil Steril 2018; 109: 6-19.
13. Nagirnaja L, Aston KI, Conrad DF. Genetic intersection of male infertility and cancer. Fertil Steril 2018; 109: 20-6.
14. James E, Jenkins TG. Epigenetics, infertility, and cancer: future directions. Fertil Steril 2018; 109: 27-32.
15. Cancer Stats Incidence 2008-UK. Cancer Research UK 2011 Registered charity in England and Wales (1089464) and Scotland (SC041666).
16. Gatta G, Zigon G, Capocaccia R, Coebergh JW, Desandes E, Kaatsch P, et al. Survival of European children and young adults with cancer diagnosed 1995-2002. Eur J Cancer 2009; 45: 992-1005.
17. Donnez J, Martinez-Madrid B, Jadoul P, Van Langendonckt A, Demylle D, Dolmans MM. Ovarian tissue cryopreservation and transplantation: a review. Hum Reprod Update 2006; 12: 519- 35.
18. Diedrich K, Fauser BC, Devroey P; Evian Annual Reproduction (EVAR) Workshop Group 2009. Cancer and fertility: strategies to preserve fertility. Reprod Biomed Online 2011; 22: 232-48.
19. Critchley HO, Wallace WH. Impact of cancer treatment on uterine function. J Natl Cancer Inst Monogr 2005; 64-8.
20. Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 2005; 62: 738-44.
21. Green DM, Whitton JA, Stovall M, Mertens AC, Donaldson SS, Ruymann FB, et al. Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Am J Obstet Gynecol 2002; 187: 1070-80.
22. Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod 2003; 18: 117-21.
23. Blumenfeld Z, von Wolff M. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum Reprod Update 2008; 14: 543-52.
24. Petrek JA, Naughton MJ, Case LD, Paskett ED, Naftalis EZ, Singletary SE, et al. Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol 2006; 24: 1045-51.
25. Broekmans FJ, Visser JA, Laven JS, Broer SL, Themmen AP, Fauser BC. Anti-Müllerian hormone and ovarian dysfunction. Trends Endocrinol Metab 2008; 19: 340-7.
26. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 2001; 7: 535-43.
27. Anderson RA, Themmen AP, Al-Qahtani A, Groome NP, Cameron DA. The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod 2006; 21: 2583-92.
28. Donnez J, Dolmans MM, Martinez-Madrid B, Demylle D, Van Langendonckt A. The role of cryopreservation for women prior to treatment of malignancy. Curr Opin Obstet Gynecol 2005; 17: 333-8.
29. Partridge AH, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M, et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 2004; 22: 4174-83.
30. Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril 2005; 83: 1622-8.
31. Eskander RN, Randall LM, Berman ML, Tewari KS, Disaia PJ, Bristow RE. Fertility preserving options in patients with gynecologic malignancies. Am J Obstet Gynecol 2011; 205: 103-10.
32. Partridge AH, Gelber S, Peppercorn J, Ginsburg E, Sampson E, Rosenberg R, et al. Fertility and menopausal outcomes in young breast cancer survivors. Clin Breast Cancer 2008; 8: 65-9.
33. de Ziegler D, Streuli I, Vasilopoulos I, Decanter C, This P, Chapron C. Cancer and fecundity issues mandate a multidisciplinary approach. Fertil Steril 2010; 93: 691-6.
34. Hatırnaz Ş, Ata B, Hatırnaz ES, Dahan MH, Tannus S, Tan J, et al. Oocyte in vitro maturation: A sytematic review. Turk J Obstet Gynecol 2018; 15: 112-25.
35. Hatirnaz S, Basbug A, Akarsu S, Hatirnaz E, Demirci H, Dahan MH. Outcomes of random start versus clomiphene citrate and gonadotropin cycles in occult premature ovarian insufficiency patients, refusing oocyte donation: a retrospective cohort study. Gynecol Endocrinol 2018; 34: 949-54.
36. Zaman K, Ambrosetti A, Perey L, Jeanneret-Sozzi W, Delaloye JF, De Ziegler D. Breast cancer in young women: adjuvant therapy and fertility. Rev Med Suisse 2007; 3: 1298-1300, 1302, 1304.
37. Armstrong K, Eisen A, Weber B. Assessing the risk of breast cancer. N Engl J Med 2000; 342: 564-71.
38. Decanter C, Morschhauser F, Pigny P, Lefebvre C, Gallo C, Dewailly D. Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results. Reprod Biomed Online 2010; 20: 280-5.
39. De Bruin ML, Huisbrink J, Hauptmann M, Kuenen MA, Ouwens GM, van't Veer MB, et al. Treatment-related risk factors for premature menopause following Hodgkin lymphoma. Blood 2008; 111: 101-8.
40. Cramer DW, Xu H, Harlow BL. Does "incessant" ovulation increase risk for early menopause? Am J Obstet Gynecol 1995; 172: 568-73.
41. Azim AA, Costantini-Ferrando M, Lostritto K, Oktay K. Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization. J Clin Endocrinol Metab 2007; 92: 2197-200.
42. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Data-base: North American Association of Central Cancer Registries (NAACCR) Incidence-ChiNA Analytic File, 1995- 2008, for Expanded Races, custom file with county, ACS Facts & Figures projection project, North American Association of Central Can-cer Registries. Bethesda: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch; 2011.
43. Howlader N, Noone AM, Yu M, Cronin KA. Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancer. Am J Epidemiol 2012; 176: 347-56.
44. Rodriguez-Wallberg KA, Oktay K. Recent advances in oocyte and ovarian tissue cryopreservation and transplantation. Best Pract Res Clin Obstet Gynaecol 2012; 26: 391-405.
45. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 2001; 7: 535-43.
46. Meirow D, Nugent D. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Hum Reprod Update 2001; 7: 535-43.
47. Cakmak H, Rosen MP. Ovarian stimulation in cancer patients. Fertil Steril 2013; 99: 1476-84.
48. Cobo A, Bellver J, Domingo J, Pérez S, Crespo J, Pellicer A, et al. New options in assisted reproduction technology: the Cryotop method of oocyte vitrification. Reprod Biomed Online 2008; 17: 68- 72.
49. Rienzi L, Romano S, Albricci L, Maggiulli R, Capalbo A, Baroni E, et al. Embryo development of fresh 'versus' vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study. Hum Reprod 2010; 25: 66-73.
50. Parmegiani L, Cognigni GE, Bernardi S, Cuomo S, Ciampaglia W, Infante FE, et al. Efficiency of aseptic open vitrification and hermetical cryostorage of human oocytes. Reprod Biomed Online 2011; 23: 505-12.
51. Anderson RA, Anckaert E, Bosch E, Dewailly D, Dunlop CE, Fehr D, et al. Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool. Fertil Steril 2015; 103: 1074-1080.e4.
52. Ozkaya E, San Roman G, Oktay K. Luteal phase GnRHa trigger in random start fertility preservation cycles. J Assist Reprod Genet 2012; 29: 503-5.
53. Sönmezer M, Türkçüoğlu I, Coşkun U, Oktay K. Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles. Fertil Steril 2011; 95: 2125.e9-11.
54. von Wolff M, Thaler CJ, Frambach T, Zeeb C, Lawrenz B, Popovici RM, et al. Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril 2009; 92: 1360-5.
55. Madrigrano A, Westphal L, Wapnir I. Egg retrieval with cryopreservation does not delay breast cancer treatment. Am J Surg 2007; 194: 477-81.
56. Kauff ND, Domchek SM, Friebel TM, Robson ME, Lee J, Garber JE, et al. Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. J Clin Oncol 2008; 26: 1331-7.
57. Dolmans MM, Marinescu C, Saussoy P, Van Langendonckt A, Amorim C, Donnez J. Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood 2010; 116: 2908-14.
58. Meirow D, Hardan I, Dor J, Fridman E, Elizur S, Ra'anani H, et al. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod 2008; 23: 1007-13.
59. Maltaris T, Seufert R, Fischl F, Schaffrath M, Pollow K, Koelbl H, et al. The effect of cancer treatment on female fertility and strategies for preserving fertility. Eur J Obstet Gynecol Reprod Biol 2007; 130: 148-55.
60. Gidoni Y, Holzer H, Tulandi T, Tan SL. Fertility preservation in patients with non-oncological conditions. Reprod Biomed Online 2008; 16: 792-800.
61. Tur-Kaspa I, Segal S, Moffa F, Massobrio M, Meltzer S. Viagra for temporary erectile dysfunction during treatments with assisted reproductive technologies. Hum Reprod 1999; 14: 1783-4.
62. Meistrich ML, Shetty G. Hormonal suppression for fertility preservation in males and females. Reproduction 2008; 136: 691-701.
63. Brook PF, Radford JA, Shalet SM, Joyce AD, Gosden RG. Isolation of germ cells from human testicular tissue for low temperature storage and autotransplantation. Fertil Steril 2001; 75: 269-74.
64. Rueffer U, Breuer K, Josting A, Lathan B, Sieber M, Manzke O, et al. Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment. Ann Oncol 2001; 12: 1307-11.
65. Orwig KE, Schlatt S. Cryopreservation and transplantation of spermatogonia and testicular tissue for preservation of male fertility. J Natl Cancer Inst Monogr 2005; 51-6.
66. Cardis E, Krewski D, Boniol M, Drozdovitch V, Darby SC, Gilbert ES, et al. Estimates of the cancer burden in Europe from radioactive fallout from the Chernobyl accident. Int J Cancer 2006; 119: 1224-35.
67. Bahadur G, Ozturk O, Muneer A, Wafa R, Ashraf A, Jaman N, et al. Semen quality before and after gonadotoxic treatment. Hum Reprod 2005; 20: 774-81.
68. Pastink A, Schalet AP, Vreeken C, Parádi E, Eeken JC. The nature of radiation-induced mutations at the white locus of Drosophila melanogaster. Mutat Res 1987; 177: 101-15.

APA	hatirnaz s, Bakay K, HATIRNAZ E, Güven D, basbug a, ÖNDER S, YILDIRIM O, Ünlü M (2019). Fertility preservation in Turkey: a global look for nationwide strategy development. , 196 - 207. 10.4274/jtgga.galenos.2019.2018.0116
Chicago	hatirnaz safak,Bakay Kadir,HATIRNAZ Ebru,Güven Davut,basbug alper,ÖNDER Sevgen Çelik,YILDIRIM Osman Gazi,Ünlü Mehmet Cihat Fertility preservation in Turkey: a global look for nationwide strategy development. (2019): 196 - 207. 10.4274/jtgga.galenos.2019.2018.0116
MLA	hatirnaz safak,Bakay Kadir,HATIRNAZ Ebru,Güven Davut,basbug alper,ÖNDER Sevgen Çelik,YILDIRIM Osman Gazi,Ünlü Mehmet Cihat Fertility preservation in Turkey: a global look for nationwide strategy development. , 2019, ss.196 - 207. 10.4274/jtgga.galenos.2019.2018.0116
AMA	hatirnaz s,Bakay K,HATIRNAZ E,Güven D,basbug a,ÖNDER S,YILDIRIM O,Ünlü M Fertility preservation in Turkey: a global look for nationwide strategy development. . 2019; 196 - 207. 10.4274/jtgga.galenos.2019.2018.0116
Vancouver	hatirnaz s,Bakay K,HATIRNAZ E,Güven D,basbug a,ÖNDER S,YILDIRIM O,Ünlü M Fertility preservation in Turkey: a global look for nationwide strategy development. . 2019; 196 - 207. 10.4274/jtgga.galenos.2019.2018.0116
IEEE	hatirnaz s,Bakay K,HATIRNAZ E,Güven D,basbug a,ÖNDER S,YILDIRIM O,Ünlü M "Fertility preservation in Turkey: a global look for nationwide strategy development." , ss.196 - 207, 2019. 10.4274/jtgga.galenos.2019.2018.0116
ISNAD	hatirnaz, safak vd. "Fertility preservation in Turkey: a global look for nationwide strategy development". (2019), 196-207. https://doi.org/10.4274/jtgga.galenos.2019.2018.0116

APA	hatirnaz s, Bakay K, HATIRNAZ E, Güven D, basbug a, ÖNDER S, YILDIRIM O, Ünlü M (2019). Fertility preservation in Turkey: a global look for nationwide strategy development. Journal of the Turkish-German Gynecological Association, 20(3), 196 - 207. 10.4274/jtgga.galenos.2019.2018.0116
Chicago	hatirnaz safak,Bakay Kadir,HATIRNAZ Ebru,Güven Davut,basbug alper,ÖNDER Sevgen Çelik,YILDIRIM Osman Gazi,Ünlü Mehmet Cihat Fertility preservation in Turkey: a global look for nationwide strategy development. Journal of the Turkish-German Gynecological Association 20, no.3 (2019): 196 - 207. 10.4274/jtgga.galenos.2019.2018.0116
MLA	hatirnaz safak,Bakay Kadir,HATIRNAZ Ebru,Güven Davut,basbug alper,ÖNDER Sevgen Çelik,YILDIRIM Osman Gazi,Ünlü Mehmet Cihat Fertility preservation in Turkey: a global look for nationwide strategy development. Journal of the Turkish-German Gynecological Association, vol.20, no.3, 2019, ss.196 - 207. 10.4274/jtgga.galenos.2019.2018.0116
AMA	hatirnaz s,Bakay K,HATIRNAZ E,Güven D,basbug a,ÖNDER S,YILDIRIM O,Ünlü M Fertility preservation in Turkey: a global look for nationwide strategy development. Journal of the Turkish-German Gynecological Association. 2019; 20(3): 196 - 207. 10.4274/jtgga.galenos.2019.2018.0116
Vancouver	hatirnaz s,Bakay K,HATIRNAZ E,Güven D,basbug a,ÖNDER S,YILDIRIM O,Ünlü M Fertility preservation in Turkey: a global look for nationwide strategy development. Journal of the Turkish-German Gynecological Association. 2019; 20(3): 196 - 207. 10.4274/jtgga.galenos.2019.2018.0116
IEEE	hatirnaz s,Bakay K,HATIRNAZ E,Güven D,basbug a,ÖNDER S,YILDIRIM O,Ünlü M "Fertility preservation in Turkey: a global look for nationwide strategy development." Journal of the Turkish-German Gynecological Association, 20, ss.196 - 207, 2019. 10.4274/jtgga.galenos.2019.2018.0116
ISNAD	hatirnaz, safak vd. "Fertility preservation in Turkey: a global look for nationwide strategy development". Journal of the Turkish-German Gynecological Association 20/3 (2019), 196-207. https://doi.org/10.4274/jtgga.galenos.2019.2018.0116